Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Select your state to see jurisdictional framework, reporting obligations, and authority links. Substance information above is the same in every state.
Terminal disease Clinical criteria: The treatment must be for the short-term, AND Patient must be receiving palliative care.
Refractory phobic or anxiety states Clinical criteria: The treatment must be for the short-term.
“Bromazepam is a benzodiazepine with anxiolytic action.”
“Bromazepam has an elimination half-life of about 17 h (range 11 – 22 h).”
“Lexotan undergoes hepatic microsomal oxidation via the cytochrome P450 liver enzymes.”
Working under the parallel aged-care framework? Aged-care equivalent →
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.